文献速递慢性静脉疾病

射频与氰基丙烯酸酯静脉腔内消融术后血栓并发症:多中心真实世界经验结局

Thrombotic complications after radiofrequency and cyanoacrylate endovenous ablation: Outcomes of a multicenter real-world experience.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2022-07-16

该回顾性研究纳入两家三级医院2018至2021年803例患者的1096例次浅静脉腔内消融术,比较射频消融(RFA,700例次)与氰基丙烯酸酯胶闭合(CAG,396例次)术后血栓并发症。RFA组和CAG组的内膜热诱导血栓(EHIT)与内膜胶诱导血栓(EGIT)发生率分别为1.9%和1.3%(P=0.57),深静脉血栓发生率分别为0.1%和0.3%(P=0.81),提示两种技术血栓发生率均较低。

要点

  • RFA与CAG术后EHIT/EGIT发生率分别为1.9%和1.3%,差异无统计学意义(P=0.57)。
  • RFA组深静脉血栓发生率0.1%,CAG组0.3%,差异无统计学意义(P=0.81)。
  • 单变量分析未发现促发血栓事件的显著危险因素。

核心结论

  • RFA和CAG闭合技术治疗慢性静脉功能不全安全,血栓发生率低于既往报道。
  • 作者认为进一步工作可能有助于明确如何在所有静脉消融技术中实现这些结果,甚至适用于晚期静脉疾病且血栓事件风险可能高于平均水平的患者人群。

研究设计与样本

  • 回顾性研究,在两家三级医院进行,纳入2018年至2021年接受浅静脉腔内消融的患者。
  • 共803例患者接受1096例次手术,平均年龄62±15岁,67%为女性。
  • 按手术类型分为ClosureFast射频消融(RFA)700例次和VenaSeal氰基丙烯酸酯胶闭合(CAG)396例次。
  • 主要终点为EHIT或EGIT发生率,次要终点为深静脉血栓和/或肺栓塞发生率。

主要发现

  • 术后7天 duplex 超声联合闭合率为98%。
  • 平均Caprini评分5.2±1.8(RFA组5.0 vs CAG组5.4,P<.001)。
  • EHIT和EGIT发生率分别为1.9%和1.3%(P=.57)。
  • 深静脉血栓发生率RFA组0.1% vs CAG组0.3%(P=.81)。
  • 对EHIT和EGIT危险因素的单变量分析未发现显著促发血栓事件的因子。

关键数值与推荐

  • 主要终点EHIT/EGIT发生率:RFA组1.9% vs CAG组1.3%(P=.57)。
  • 次要终点深静脉血栓发生率:RFA组0.1% vs CAG组0.3%(P=.81)。
  • 平均Caprini评分:RFA组5.0 vs CAG组5.4(P<.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Chronic venous insufficiency (CVI) affects >40% of the U.S. population; thus, intervention for symptomatic venous disease comprises a large portion of many vascular practices. The treatment of superficial CVI has evolved from open surgical treatment to minimally invasive endovenous closure, including both thermal and nonthermal techniques. Thrombotic complications of thermal ablation have been well reported, with an overall complication rate of <2%. However, a paucity of high-powered, real-world data is available on the thrombotic outcomes of nonthermal techniques. In the present study, we compared the incidence of endovenous heat-induced thrombosis (EHIT) and endovenous glue-induced thrombosis (EGIT) in a large cohort of patients with CVI. METHODS: A retrospective review was conducted at two tertiary-level institutions of patients who had undergone superficial endovenous ablation from 2018 to 2021. The patient demographics, comorbidities, and periprocedural outcomes were collected through medical record review. A Caprini risk assessment model score was assigned using the information available from the electronic medical records. The patients were categorized by procedure type (ClosureFast [Medtronic Inc, Minneapolis, MN] radiofrequency ablation [RFA] vs VenaSeal [Medtronic Inc] cyanoacrylate glue closure [CAG]). The primary end point was the incidence of EHIT or EGIT. The secondary end point was the incidence of deep vein thrombosis and/or pulmonary embolism. RESULTS: A total of 803 patients had undergone 1096 procedures during the study period. Their mean age was 62 ± 15 years, and 67% were women. Of the 1096 procedures, 700 were RFA and 396 were CAG procedures, with a combined closure rate of 98% by postprocedure duplex ultrasound at 7 days. The average Caprini score was 5.2 ± 1.8 (RFA, 5.0; vs CAG, 5.4; P < .001). The incidence of EHIT and EGIT was 1.9% and 1.3%, respectively (P = .57). The deep vein thrombosis rate was 0.1% in the RFA cohort and 0.3% in the CAG cohort (P = .81). A comparative analysis of thermal vs nonthermal techniques was performed. A univariate analysis of the risk factors for EHIT and EGIT revealed no significant factors predisposing to thrombotic events. CONCLUSIONS: The results from the present study have demonstrated the safety of RFA and CAG closure techniques for CVI, with lower thrombotic rates than previously reported. Further work might help to identify how these results can be achieved across all venous ablative techniques for CVI, even for patient populations with advanced venous disease and possibly a greater than average risk of thrombotic events.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. O'Banion LAA, Siada S, Cutler B, et al. Thrombotic complications after radiofrequency and cyanoacrylate endovenous ablation: Outcomes of a multicenter real-world experience. J Vasc Surg Venous Lymphat Disord. 2022. PMID: 35843596. doi:10.1016/j.jvsv.2022.05.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。